Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.



<ul>
<li>Bernstein analyst Cristian Rios initiated coverage on PepsiCo Inc (NASDAQ:PEP) with a Market Perform rating and announced a price target of $143. PepsiCo shares closed at $143.73 on Thursday. See how other analysts view this stock.</li>



<li>Evercore ISI Group analyst Kirk Materne initiated coverage on Octave Intelligence PLC (NASDAQ:OCTV) with an In-Line rating and announced a price target of $20. Octave Intelligence shares closed at $18.33 on Thursday. See how other analysts view this stock.</li>



<li>Roth Capital analyst Justin Clare initiated coverage on Fervo Energy (NASDAQ:FRVO) with a Buy rating and announced a price target of $45. Fervo Energy shares closed at $34.64 on Thursday. See how other analysts view this stock.</li>



<li>B of A Securities analyst Alec Stranahan initiated coverage on Avalo Therapeutics Inc (NASDAQ:AVTX) with a Buy rating and announced a price target of $35. Avalo Therapeutics shares closed at $13.67 on Thursday. See how other analysts view this stock.</li>



<li>Bernstein analyst Cristian Rios initiated coverage on Keurig Dr Pepper Inc (NASDAQ:KDP) with an Outperform rating and announced a price target of $38. Keurig Dr Pepper shares closed at $31.23 on Thursday. See how other analysts view this stock.</li>
</ul>



Considering buying KDP stock? Here’s what analysts think:



<figure class="wp-block-image size-large is-resized"></figure>



Photo via Shutterstock

AVTX

FRVO

OCTV

Wall Street analysts initiated coverage on several companies this Friday. Bernstein's Cristian Rios started Keurig Dr Pepper (KDP) with an Outperform rating and a $38 price target, while also covering PepsiCo (PEP) with Market Perform and a $143 target. Other initiations include Evercore ISI's In-Line rating for Octave Intelligence (OCTV) at $20, Roth Capital's Buy rating for Fervo Energy (FRVO) at $45, and B of A Securities' Buy rating for Avalo Therapeutics (AVTX) at $35.

benzinga_article

PepsiCo

Avalo Therapeutics

Keurig Dr Pepper

Fervo Energy

Octave Intelligence

This Keurig Dr Pepper Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday